TrialFind
Saved trials
Back to results
Recruiting
Phase 3
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
NCT04602754
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Allergisa
Campinas, São Paulo, Brazil
Contact
Cassiano O Berto, BD
+551938877724
pesquisa.clinica@ncfarma.com.br
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. — TrialFind